Patrick Wen

Professor of Neurology, Director, Center for Neuro-Oncology · Boston University Medical Center

Credentials: · · ·

History

Malignant gliomas in adults
Review · New England Journal of Medicine · 2008 · First of 2 authors · Corresponding · 3,351 citations
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group
Journal of Clinical Oncology · 2010 · First of 19 authors · Corresponding · 3,116 citations
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
Journal of Clinical Oncology · 2009 · 2,000 citations

Targeted Therapies for Glioma
National Cancer Institute · P50
Project lead · $609.2K · Brigham and Women's Hospital
2016
Therapeutics Studies of Primary CNS Malignancies
National Cancer Institute · U01
Contact PI · $1.2M · Dana-Farber Cancer Inst
1994–2008
Immunotherapy for Malignant Gliomas
National Cancer Institute · K11
Contact PI · $427K · Brigham and Women's Hospital
1990–1995

Abemaciclib + Pembrolizumab In Glioblastoma
Principal investigator · Withdrawn · Phase 2
Dana-Farber Cancer Institute
2021–2024
Surgical Nivolumab And Ipilimumab For Recurrent GBM
Principal investigator · Active not recruiting · Phase 1
Patrick Wen, MD
2021–2026
VB-111 in Surgically Accessible Recurrent/Progressive GBM
Principal investigator · Terminated · Phase 2
Dana-Farber Cancer Institute
2020–2024
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Principal investigator · Active not recruiting · Phase 1
AstraZeneca
2018–2026